Losartan Potassium Tablets USP — Class II drug recall D-1545-2020
Terminated recall by Hetero Labs Limited (Unit V), reported 2020-09-02, distributed nationwide. Failed Tablet/Capsule Specification; complaint of bulging tablet
| Recall number | D-1545-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hetero Labs Limited (Unit V), Badepalle, N/A, India |
| Recall initiated | 2020-08-06 |
| Classified | 2020-08-26 |
| Reported by FDA | 2020-09-02 |
| Terminated | 2022-01-24 |
| Distributed | Nationwide (US) |
| Quantity | 43,512 bottles |
| Lot numbers | LOA19357A |
| Expiration dates | 2021-09 |
Product
Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India
Reason for recall
Failed Tablet/Capsule Specification; complaint of bulging tablet
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1545-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.